(Q51025938)

27 March 2018

title

Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients. (English)

1 reference

27 March 2018

chronic idiopathic myelofibrosis

1 reference

1 reference

2

1 reference

27 March 2018

Ayalew Tefferi

7

object named as

A Tefferi

1 reference

27 March 2018

A Pardanani

1

1 reference

27 March 2018

T L Lasho

3

1 reference

27 March 2018

A Pancrazzi

4

1 reference

27 March 2018

C M Finke

5

1 reference

27 March 2018

A M Vannucchi

6

1 reference

27 March 2018

publication date

21 June 2011

1 reference

27 March 2018

published in

Leukemia

1 reference

27 March 2018

volume

25

1 reference

27 March 2018

issue

12

1 reference

27 March 2018

page(s)

1834-1839

1 reference

27 March 2018

https://scigraph.springernature.com/pub.10.1038/leu.2011.161

exact match

0 references

cites work

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Anaemia characterises patients with myelofibrosis harbouring Mpl mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

MPLW515L mutation in acute megakaryoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Two rare MPL gene mutations in patients with essential thrombocythemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

A sensitive detection method for MPLW515L or MPLW515K mutation in chronic myeloproliferative disorders with locked nucleic acid-modified probes and real-time polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

7 January 2021

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

7 January 2021

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

7 January 2021

Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.161

7 January 2021

Identifiers

DOI

10.1038/LEU.2011.161

1 reference

27 March 2018

1 reference

27 March 2018